← Back to Search

Other

AOC 1020 for Facioscapulohumeral Muscular Dystrophy (FORTITUDE-OLE Trial)

Phase 2
Waitlist Available
Research Sponsored by Avidity Biosciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Unwilling or unable to comply with contraceptive requirements for the length of AOC 1020-CS2
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

"This trial will study the long-term effects of AOC 1020 given through an IV to adults with Facioscapulohumeral Muscular Dystrophy (FSHD)."

Who is the study for?
This trial is for adults with Facioscapulohumeral Muscular Dystrophy (FSHD), a type of muscular dystrophy that affects the muscles of the face, shoulder blades, and upper arms. Participants should have completed prior studies with AOC 1020 or meet specific health criteria.
What is being tested?
The study tests long-term safety and effectiveness of AOC 1020 when given through an IV. It's an open-label extension, meaning everyone knows they're getting AOC 1020 and there's no placebo group.
What are the potential side effects?
Possible side effects are not detailed here but typically include reactions at the infusion site, muscle pain or weakness, fatigue, and potential allergic responses to the medication.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot or will not follow the birth control rules during the AOC 1020-CS2 study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Experimental Treatment
Group I: AOC 1020 RegimenExperimental Treatment1 Intervention
AOC 1020 Dose Regimen; Nine doses administered intravenously over 24 months. Treatment assignment will be based on treatment received in AOC 1020-CS1.

Find a Location

Who is running the clinical trial?

Avidity Biosciences, Inc.Lead Sponsor
7 Previous Clinical Trials
835 Total Patients Enrolled
Amy Halseth, Ph.D.Study DirectorAvidity Biosciences, Inc.
~48 spots leftby Apr 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top